IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2.
Nikitin PA, DiMuzio JM, Dowling JP, Patel NB, Bingaman-Steele JL, Heimbach BC, Henriquez N, Nicolescu C, Polley A, Sikorski EL, Howanski RJ, Nath M, Shukla H, Scheaffer SM, Finn JP, Liang LF, Smith T, Storm N, McKay LGA, Johnson RI, Malsick LE, Honko AN, Griffiths A, Diamond MS, Sarma P, Geising DH, Morin MJ, Robinson MK.
Nikitin PA, et al. Among authors: polley a.
Sci Immunol. 2022 Sep 9;7(75):eabl9943. doi: 10.1126/sciimmunol.abl9943. Epub 2022 Sep 9.
Sci Immunol. 2022.
PMID: 35771946
Free PMC article.